Literature DB >> 10569767

Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.

B Schroeder1, M D Boyle, B R Sheerin, A C Asbury, R Lottenberg.   

Abstract

Our laboratory previously demonstrated that group C streptococcal isolates from humans and horses secrete streptokinases that preferentially activate plasminogens reflecting the origin of the isolates. To analyze the significance of these findings, series of streptokinase-producing Streptococcus equisimilis isolates recovered from humans and horses were examined. Southern blot analysis revealed that chromosomal DNA of the streptococcal isolates from humans reacted exclusively with a skc(hu) probe and that chromosomal DNA of streptococcal isolates from horses reacted preferentially with an skc(eq) probe in a distinct pattern. The streptococcal isolates were examined for the ability to acquire surface-bound plasmin-like activity when grown in the presence of human or equine plasma. Each of eight isolates from humans acquired significant enzymatic activity only when grown in the presence of human plasma, while each of eight isolates from horses acquired activity only when grown in the presence of equine plasma. Analysis of bacterial and host protein requirements indicated critical roles for streptokinase, activatable plasminogen, and fibrinogen. These requirements may explain why certain streptococcal isolates cause disease only in a limited number of mammalian hosts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569767      PMCID: PMC97059          DOI: 10.1128/IAI.67.12.6487-6495.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Heterogeneity of the streptokinase gene in group A streptococci.

Authors:  T T Huang; H Malke; J J Ferretti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Receptors for human plasminogen on gram-negative bacteria.

Authors:  M Ullberg; G Kronvall; I Karlsson; B Wiman
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 3.  Species specificity of streptokinase.

Authors:  J A Marcum; D L Kline
Journal:  Comp Biochem Physiol B       Date:  1983

Review 4.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

5.  Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci.

Authors:  C C Broder; R Lottenberg; M D Boyle
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Recurring thromboembolic disease and pulmonary hypertension associated with severe hypoplasminogenemia.

Authors:  R Lottenberg; F R Dolly; C S Kitchens
Journal:  Am J Hematol       Date:  1985-06       Impact factor: 10.047

8.  Comparative activation kinetics of mammalian plasminogens.

Authors:  R C Wohl; L Sinio; L Summaria; K C Robbins
Journal:  Biochim Biophys Acta       Date:  1983-05-30

9.  Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation.

Authors:  H E McCoy; C C Broder; R Lottenberg
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

10.  A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.

Authors:  H McNeill; P J Jensen
Journal:  Cell Regul       Date:  1990-10
View more
  9 in total

1.  Coevolutionary patterns in plasminogen activation.

Authors:  Inna P Gladysheva; Ryan B Turner; Irina Y Sazonova; Lin Liu; Guy L Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

Review 2.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

Review 3.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

4.  Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.

Authors:  Anthony R Flores; Brittany E Jewell; Randall J Olsen; Samuel A Shelburne; Nahuel Fittipaldi; Stephen B Beres; James M Musser
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

5.  Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice.

Authors:  Hongmin Sun; Yuanxi Xu; Izabela Sitkiewicz; Yibao Ma; Xixi Wang; Bryan D Yestrepsky; Yuping Huang; Martian C Lapadatescu; Martha J Larsen; Scott D Larsen; James M Musser; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

6.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

7.  Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations.

Authors:  Awdhesh Kalia; Debra E Bessen
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

8.  Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains.

Authors:  Anthony R Flores; Randall J Olsen; Andrea Wunsche; Muthiah Kumaraswami; Samuel A Shelburne; Ronan K Carroll; James M Musser
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

Review 9.  Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.

Authors:  Anne-Marije Hulshof; H Coenraad Hemker; Henri M H Spronk; Yvonne M C Henskens; Hugo Ten Cate
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.